179 related articles for article (PubMed ID: 37215455)
1. Activation of the HNRNPA2B1/
Sun M; Shen Y; Jia G; Deng Z; Shi F; Jing Y; Xia S
J Cancer; 2023; 14(7):1242-1256. PubMed ID: 37215455
[TBL] [Abstract][Full Text] [Related]
2. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
[TBL] [Abstract][Full Text] [Related]
3. HNRNPA2B1-mediated m
Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
[TBL] [Abstract][Full Text] [Related]
4. Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis.
Chen Z; Chen X; Lei T; Gu Y; Gu J; Huang J; Lu B; Yuan L; Sun M; Wang Z
Mol Ther; 2020 Jun; 28(6):1479-1493. PubMed ID: 32246902
[TBL] [Abstract][Full Text] [Related]
5. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
Rong L; Xu Y; Zhang K; Jin L; Liu X
Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
[TBL] [Abstract][Full Text] [Related]
6. Identification of miR-30c-5p as a tumor suppressor by targeting the m
Wu Q; Li G; Gong L; Cai J; Chen L; Xu X; Liu X; Zhao J; Zeng Y; Gao R; Yu L; Wang Z
Cancer Med; 2023 Feb; 12(4):5055-5070. PubMed ID: 36259156
[TBL] [Abstract][Full Text] [Related]
7. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
[TBL] [Abstract][Full Text] [Related]
8. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
[TBL] [Abstract][Full Text] [Related]
9. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
Li D; Fu Z; Dong C; Song Y
Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
[TBL] [Abstract][Full Text] [Related]
10. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma.
Wang W; Li S
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37877146
[TBL] [Abstract][Full Text] [Related]
12. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
14. HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression.
Hu T; Zeng C; Song Z; Liu Q; Chen S; Huang W; Ma Q; Li H
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167050. PubMed ID: 38331110
[TBL] [Abstract][Full Text] [Related]
15. HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster.
Li K; Chen J; Lou X; Li Y; Qian B; Xu D; Wu Y; Ma S; Zhang D; Cui W
Front Cell Dev Biol; 2021; 9():658642. PubMed ID: 34277606
[TBL] [Abstract][Full Text] [Related]
16. HnRNPA2B1 ISGylation Regulates m6A-Tagged mRNA Selective Export via ALYREF/NXF1 Complex to Foster Breast Cancer Development.
Jin T; Yang L; Chang C; Luo H; Wang R; Gan Y; Sun Y; Guo Y; Tang R; Chen S; Meng D; Dai P; Liu M
Adv Sci (Weinh); 2024 Apr; ():e2307639. PubMed ID: 38626369
[TBL] [Abstract][Full Text] [Related]
17. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
18. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
[TBL] [Abstract][Full Text] [Related]
19. METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.
Gong WJ; Li R; Dai QQ; Yu P
J Gastroenterol Hepatol; 2022 Dec; 37(12):2229-2242. PubMed ID: 36068012
[TBL] [Abstract][Full Text] [Related]
20. HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer.
Li Y; Li K; Lou X; Wu Y; Seery S; Xu D; Pei Y; Qian B; Wu Y; Liang S; Wu K; Cui W
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
